PCBL Chemical Limited has released its monitoring agency report for the quarter ended September 30, 2025. The report, issued by CRISIL Ratings Limited, pertains to the preferential issue of warrants convertible into equity shares. No proceeds were utilized for the object of the issue during the reported quarter. The company awaits the exercise of warrants by holders to further utilize funds.
Monitoring Agency Findings
The monitoring agency report by CRISIL Ratings Limited addresses the preferential issue of warrants convertible into equity shares of PCBL Chemical Limited. The report confirms adherence to regulations and provides an overview of the utilization of issue proceeds.
Key Report Details
According to the report for the quarter ended September 30, 2025, no proceeds from the preferential issue were utilized during the specified period. As of the report date, the company’s total unutilized amount stands at ₹336 crore. This amount represents proceeds pending utilization, contingent upon the exercise of warrants by the respective holders.
Anticipated Fund Utilization
PCBL Chemical anticipates receiving the remaining ₹336.00 crore within 18 months from the date of allotment of share warrants, specifically by November 06, 2025. Once received, these funds will be allocated according to the company’s pre-defined objectives.
Utilization Objectives
The funds are primarily earmarked for debt repayment of the company and its subsidiaries (₹168,00,00,000.00) and funding working capital (₹168,00,00,000.00). A portion (₹112,00,00,000.00) is designated for general corporate purposes. These allocations will support PCBL Chemical’s growth strategies.
Source: BSE
